Table 1 Relationship between EPB41L4A-AS1 expression and different clinicopathologic features in patients with gastric cancer
Indicators | Cases (n = 110) | EPB41L4A-AS1 expression level | P | |
|---|---|---|---|---|
Low (n = 66) | High (n = 44) | |||
Age (years) | 0.640 | |||
≤ 55 | 57 | 33 | 24 | |
> 55 | 53 | 33 | 20 | |
Tumor size (cm) | 0.087 | |||
≤ 5 | 54 | 28 | 26 | |
> 5 | 56 | 38 | 18 | |
Sex | 0.160 | |||
Female | 51 | 27 | 24 | |
Male | 59 | 39 | 20 | |
Differentiation | 0.186 | |||
Well, Moderate | 54 | 29 | 25 | |
Poor | 56 | 37 | 19 | |
Lymph node metastasis | 0.035 | |||
Negative | 59 | 30 | 29 | |
Positive | 51 | 36 | 15 | |
TNM stage | 0.024 | |||
I, II | 53 | 26 | 27 | |
III, IV | 57 | 40 | 17 | |